Stocks & ETFs Screener: 102 results (Pharmaceuticals)
| Symbol | Industry | Market Cap | Fund. Score | Div. Score | Tech. Score | P/E | Return 12m vs S&P 500 |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly |
Pharmaceuticals
Insulin, Diabetes, Oncology |
747B | 76.0% | 70.2% | 42.4% | 54.4 | -22.7% |
| JNJ Johnson & Johnson |
Pharmaceuticals
Pharmaceuticals, Medical Devices |
460B | 76.2% | 58.2% | 50.9% | 20.5 | 6.18% |
| ZEG AstraZeneca |
Pharmaceuticals
Oncology, Respiratory |
267B | 81.7% | 42.5% | 34.0% | 32.6 | -8.96% |
| AZN AstraZeneca |
Pharmaceuticals
Oncology, Cardiovascular |
266B | 77.1% | 40.2% | 69.9% | 32.1 | -3.82% |
| NVO Novo Nordisk |
Pharmaceuticals
Insulin, Obesity Medication |
263B | 87.7% | 63.0% | -14.9% | 15.1 | -57.1% |
| NVS Novartis |
Pharmaceuticals
Cardiovascular,Oncology,Immunology,.. |
252B | 87.9% | 59.8% | 88.6% | 18.9 | 0.15% |
| MRK Merck |
Pharmaceuticals
Keytruda, Gardasil, Januvia |
219B | 86.6% | 67.2% | -14.6% | 13.5 | -29.5% |
| PFE Pfizer |
Pharmaceuticals
Vaccines, Antivirals, Oncology |
144B | 60.7% | 71.3% | -46.4% | 13.4 | -20.8% |
| SNY Sanofi |
Pharmaceuticals
Vaccines, Oncology, Immunology |
124B | 55.5% | 56.0% | 34.1% | 16.9 | -19.2% |
| SAN Sanofi |
Pharmaceuticals
Immunology, Oncology, Neurology |
120B | 66.3% | 64.3% | -4.20% | 16.5 | -24.7% |
| BMY Bristol-Myers |
Pharmaceuticals
Oncology, Hematology, Immunology |
89.5B | 74.9% | 61.8% | -54.7% | 17.7 | -24.5% |
| GS71 GSK |
Pharmaceuticals
Vaccines, Specialty Medicines |
88.3B | 76.0% | 21.6% | 42.2% | 19.9 | -4.51% |
| GSK GlaxoSmithKline |
Pharmaceuticals
Vaccines, Specialty Medicines |
87.5B | 77.4% | 27.1% | 70.1% | 19.5 | 1.66% |
| ZTS Zoetis |
Pharmaceuticals
Vaccines, Parasiticides |
64.9B | 84.0% | 68.3% | -36.4% | 25.3 | -34.9% |
| MRK Merck KGaA |
Pharmaceuticals
Reagents, Drugs, Pigments |
59.6B | 59.2% | 38.3% | -57.7% | 17.9 | -34.0% |
| TAK Takeda |
Pharmaceuticals
Gastroenterology, Oncology, Rare |
43.6B | 61.6% | 26.7% | 36.7% | 49.0 | -12.9% |
| BAYN Bayer NA |
Pharmaceuticals
Pharmaceuticals, Consumer Health |
32.1B | 49.1% | 1.0% | -14.1% | - | -6.98% |
| TEVA Teva Pharma |
Pharmaceuticals
Generic Drugs, Corticosteroid |
23.4B | 48.7% | 18.1% | 55.3% | - | 1.11% |
| RPRX Royalty Pharma |
Pharmaceuticals
Royalties, Cancer, Rare Disease |
21.3B | 50.2% | 72.0% | 18.0% | 15.9 | 13.8% |
| VTRS Viatris |
Pharmaceuticals
Generic Drugs, Biosimilars |
11.9B | 35.2% | 61.0% | -19.2% | - | -21.0% |
| RDY Dr. Reddy’s |
Pharmaceuticals
Generic Medicines, Active |
11.8B | 77.6% | 48.4% | 37.4% | 18.4 | -20.2% |
| IPN Ipsen |
Pharmaceuticals
Oncology Drugs, Neuroscience |
11.3B | 89.0% | 50.0% | 26.7% | 22.0 | -11.3% |
| ELAN Elanco Animal |
Pharmaceuticals
Parasiticides, Vaccines |
10.2B | 49.9% | - | 38.0% | 23.3 | 21.4% |
| CORT Corcept |
Pharmaceuticals
Hormonemodulator, Korlym |
9.29B | 83.2% | - | 85.8% | 78.7 | 37.5% |
| VRNA Verona Pharma |
Pharmaceuticals
Inhaled |
9.09B | 29.8% | - | 96.5% | - | 169% |
| JAZZ Jazz |
Pharmaceuticals
Oxybate,Sleep,Seizure,Cancer,HEMATO.. |
8.30B | 53.4% | - | -9.04% | - | 5.97% |
| AXSM Axsome Therapeutics |
Pharmaceuticals
Auvelity, Sunosi, Symbravo, AXS-05 |
5.87B | 33.9% | - | 81.8% | - | 23.5% |
| PBH Prestige Brand |
Pharmaceuticals
Pain Powders, Diaper Rash Cream |
3.15B | 65.8% | 0.21% | 13.7% | 15.0 | -23.2% |
| AMRX Amneal |
Pharmaceuticals
Generics, Injectables |
3.14B | 57.4% | - | 61.2% | - | -1.97% |
| PRGO Perrigo |
Pharmaceuticals
Cough Relief, Infant Formula |
3.05B | 42.6% | 66.2% | -56.2% | - | -20.4% |
| VIRP Virbac |
Pharmaceuticals
Vaccines, Antibiotics |
3.01B | 86.2% | 58.0% | 15.8% | 19.5 | -27.5% |
| OGN Organon |
Pharmaceuticals
Contraception, Fertility |
2.84B | 55.6% | 56.7% | -81.6% | 4.07 | -51.9% |
| HCM HUTCHMED DRC |
Pharmaceuticals
Fruquintinib, Savolitinib |
2.77B | 34.8% | - | 13.9% | 6.08 | -31.3% |
| SUPN Supernus |
Pharmaceuticals
ADHD,Parkinsons,Epilepsy,Migraine,M.. |
2.69B | 72.7% | - | 38.2% | 41.7 | 28.0% |
| TARS Tarsus |
Pharmaceuticals
Demodex, Blepharitis, Mites, Eye |
2.48B | 37.0% | - | 58.0% | - | 67.9% |
| OCUL Ocular Therapeutix |
Pharmaceuticals
Hydrogel,Eye,Injection,Sustained-Re.. |
2.34B | 30.4% | - | 46.5% | - | -1.36% |
| TLRY Tilray |
Pharmaceuticals
Cannabis,Beverage,Wellness,Distribu.. |
2.33B | 32.8% | - | -54.5% | - | -7.46% |
| BHC Bausch Health |
Pharmaceuticals
Prescription,Surgical,Ophthalmology.. |
2.25B | 58.5% | 4.23% | -46.7% | 23.3 | -35.4% |
| DMP Dermapharm Holding |
Pharmaceuticals
Generics, Biosimilars |
2.06B | 69.4% | 50.9% | -27.5% | 16.6 | -8.95% |
| ANIP ANI Pharmaceuticals |
Pharmaceuticals
Prescription, Specialty, Generic |
2.00B | 57.2% | - | 91.9% | - | 31.9% |
| LQDA Liquidia |
Pharmaceuticals
Inhaled,Liquid,Artery,Cancer,Pulmon.. |
1.96B | 28.3% | - | 93.4% | - | 85.9% |
| HROW Harrow Health |
Pharmaceuticals
Pharmaceutical,Imprinted,Drogs,Oint.. |
1.68B | 40.9% | - | 44.0% | - | -33.7% |
| HRMY Harmony |
Pharmaceuticals
Medication, Wakix, Narcolepsy |
1.58B | 90.3% | - | -41.8% | 8.88 | -35.3% |
| PAHC Phibro Animal |
Pharmaceuticals
Animal Health, Medicated Feed |
1.50B | 58.6% | 34.8% | 71.2% | 31.2 | 33.5% |
| AVDL Avadel |
Pharmaceuticals
Hypnotic, Narcolepsy, Lymphatic |
1.45B | 57.9% | - | 53.7% | - | -6.12% |
| AMLX Amylyx |
Pharmaceuticals
Avexitide, Amx0035, Amx0114 |
1.42B | 37.7% | - | -12.6% | - | 243% |
| EVT Evotec SE |
Pharmaceuticals
Drug Discovery, Small Molecules |
1.39B | 33.3% | - | -59.9% | - | 11.2% |
| XERS Xeris |
Pharmaceuticals
Injectable, Glucagon, Diabetes |
1.32B | 42.4% | - | 80.3% | - | 133% |
| RAPP Rapport |
Pharmaceuticals
SmallMolecule, CNS, RAP-219 |
1.32B | 37.2% | - | 18.6% | 23.8 | -6.51% |
| AMPH Amphastar P |
Pharmaceuticals
Enoxaparin, Insulin, Glucagon |
1.23B | 73.2% | - | -32.4% | 9.93 | -58.5% |
| TRVI Trevi Therapeutics |
Pharmaceuticals
Investigational, Therapy, Chronic |
1.20B | 31.9% | - | 87.9% | - | 166% |
| INVA Innoviva |
Pharmaceuticals
Antibiotics, Respiratory |
1.20B | 76.4% | 2.39% | 23.8% | 33.4 | -25.9% |
| ELVN Enliven |
Pharmaceuticals
Kinase,Inhibitors,Oncology,Pipeline |
1.18B | 29.0% | - | -8.63% | - | -35.1% |
| NKTR Nektar Therapeutics |
Pharmaceuticals
Oncology, Antiviral, Immunology |
1.15B | 28.4% | - | 8.0% | - | 152% |
| WVE Wave Life Sciences |
Pharmaceuticals
Genetic, Therapy, DNA, RNA |
1.14B | 31.3% | - | 5.81% | - | -22.3% |
| PCRX Pacira BioSciences |
Pharmaceuticals
Bupivacaine,Anesthetic,Injectable |
1.10B | 47.4% | - | -22.9% | - | 18.8% |
| COLL Collegium |
Pharmaceuticals
Oxycodone, Hydrocodone, Opioid |
1.08B | 73.8% | - | 40.3% | 32.3 | -26.6% |
| CRON Cronos |
Pharmaceuticals
Cannabis, Edibles, Oils, Vapes |
993M | 38.3% | - | -8.59% | 51.8 | 0.92% |
| EYPT Eyepoint |
Pharmaceuticals
Therapeutics, Retinal, Durasert |
931M | 33.3% | - | 45.7% | - | 14.2% |
| SEPN Septerna, Common |
Pharmaceuticals
Oral Small Molecules, GPCR |
927M | 34.0% | - | 23.1% | - | 15.5% |
| PHAT Phathom |
Pharmaceuticals
GERD,Heartburn,H.Pylori,Esophagitis |
866M | 61.1% | - | -11.8% | - | -28.6% |
| CRMD CorMedix |
Pharmaceuticals
Antibiotic, Dialysis, Catheter |
863M | 89.9% | - | 58.8% | 14.2 | -8.43% |
| TBPH Theravance |
Pharmaceuticals
YUPELRI, Ampreloxetine, TRELEGY |
727M | 82.9% | - | 45.9% | 60.1 | 47.3% |
| AQST Aquestive |
Pharmaceuticals
Film,Klaxx,Film,Sublingual,Epinephr.. |
722M | 52.4% | - | 46.8% | - | 19.8% |
| ARVN Arvinas |
Pharmaceuticals
Protein Degraders, PROTAC, Cancer |
716M | 40.4% | - | -82.9% | - | -66.8% |
| TERN Terns |
Pharmaceuticals
Oncology, Obesity, Cancer |
703M | 31.2% | - | 1.33% | - | -6.31% |
| SNDL SNDL |
Pharmaceuticals
Cannabis, Wine, Beers, Spirits |
649M | 47.2% | - | -2.76% | - | 7.43% |
| SIGA SIGA Technologies |
Pharmaceuticals
Antiviral, Pharmaceuticals |
641M | 84.5% | 85.8% | 36.7% | 7.85 | 17.7% |
| ETON Eton |
Pharmaceuticals
Rare Disease Treatments |
531M | 44.3% | - | 76.9% | - | 92.2% |
| MAZE Maze Therapeutics |
Pharmaceuticals
Small Molecule Inhibitors, Kidney |
525M | 37.2% | - | 84.1% | - | 61.5% |
| FULC Fulcrum |
Pharmaceuticals
Small Molecules, Fetal Hemoglobin |
499M | 23.7% | - | 29.7% | - | 113% |
| CGC Canopy Growth |
Pharmaceuticals
Cannabis, Hemp, Extracts, Edibles |
466M | 12.4% | - | -86.8% | - | -71.5% |
| EOLS Evolus |
Pharmaceuticals
Jeuveau, Evolysse |
398M | 27.1% | - | -48.8% | - | -69.7% |
| ACB Aurora Cannabis |
Pharmaceuticals
Cannabis, Cannabis-Derivative |
335M | 47.8% | - | -41.2% | - | -16.3% |
| ALTS ALT5 Sigma |
Pharmaceuticals
Trading, Payments, Tokenization |
329M | 27.2% | 1.0% | 29.7% | - | 18.9% |
| SCPH Scpharmaceuticals |
Pharmaceuticals
Furosemide, Infusor, Diuretic |
304M | 45.6% | - | 26.1% | - | 16.0% |
| CTNM Contineum |
Pharmaceuticals
CNS,Pain,Inflammation |
301M | 31.2% | - | -64.5% | - | -36.9% |
| NMRA Neumora |
Pharmaceuticals
Depression, Schizophrenia |
288M | 37.8% | - | -80.2% | - | -89.6% |
| OMER Omeros |
Pharmaceuticals
Drug, Omid, Pegcetacoplan |
285M | 38.1% | - | -13.1% | - | -8.11% |
| AARD Aardvark |
Pharmaceuticals
SmallMolecule Therapeutics, Oral |
284M | 34.7% | - | 17.0% | - | -6.80% |
| VTYX Ventyx Biosciences |
Pharmaceuticals
Drug, Immune, Skin, Bowel |
257M | 41.7% | - | -29.1% | - | 38.0% |
| OGI OrganiGram Holdings |
Pharmaceuticals
Cannabis, Vapes, Beverages |
252M | 41.9% | - | -41.4% | 188 | -5.55% |
| TVRD Tvardi |
Pharmaceuticals
STAT3, Inhibitor, Cancer |
242M | 59.6% | - | -39.3% | - | -36.8% |
| ZYBT Zhengye |
Pharmaceuticals
Veterinary Vaccines, Livestock |
235M | 44.5% | - | -30.0% | 83.2 | -48.2% |
| MDWD Mediwound |
Pharmaceuticals
BurnTreatment, WoundCare |
226M | 34.1% | - | 35.0% | - | -11.2% |
| AVIR Atea |
Pharmaceuticals
Antiviral Therapeutics, Hepatitis |
224M | 44.4% | - | -48.5% | - | -23.3% |
| BIOA BioAge Labs |
Pharmaceuticals
Oral Small Molecules, Obesity |
201M | 56.9% | - | -68.4% | - | -80.2% |
| ACRS Aclaris |
Pharmaceuticals
Hair Loss, Skin Lesion, Immune |
199M | 28.4% | - | -50.7% | - | 38.6% |
| ELTX Elicio Therapeutics |
Pharmaceuticals
Amphiphile,Lymph,Node,Cancer,Vaccin.. |
181M | 47.0% | - | 20.2% | - | 101% |
| SAVA Cassava Sciences |
Pharmaceuticals
Alzheimers Drug, Pipeline |
181M | 33.9% | 0.17% | -74.3% | - | -87.0% |
| MIST Milestone |
Pharmaceuticals
Cardiovascular, Drug Development |
170M | 22.3% | - | -40.3% | - | 17.1% |
| SCLX Scilex Holding |
Pharmaceuticals
Topical, Non-Opioid, Pain Relief |
117M | 66.9% | - | -73.3% | - | -53.4% |
| IRD Opus Genetics |
Pharmaceuticals
Eye Drops, Retinal Therapy, Vision |
113M | 37.5% | - | -11.8% | - | 39.3% |
| NTHI NeOnc Technologies |
Pharmaceuticals
Brain, Tumor, Cancer, Drugs |
90.8M | 53.6% | - | -18.8% | - | -20.4% |
| RLMD Relmada |
Pharmaceuticals
Controlled-Release Formulation |
77.0M | 44.9% | - | -57.9% | - | -47.5% |
| TELO Telomir |
Pharmaceuticals
Small Molecule, Metal Ion |
55.8M | 45.7% | - | -92.6% | - | -70.4% |
| AYTU Aytu BioScience |
Pharmaceuticals
Adhd, Antihistamine |
24.9M | 30.0% | - | -18.3% | - | -9.85% |
| PRPH ProPhase Labs |
Pharmaceuticals
Dietary Supplements, COVID-19 |
21.9M | 20.9% | 1.0% | -78.5% | - | -81.5% |
| HOTH Hoth Therapeutics |
Pharmaceuticals
Skin, Brain, Allergy |
21.0M | 33.2% | - | -21.9% | - | 62.5% |
| ASBP Aspire BioPharma |
Pharmaceuticals
Instaprin, Sublingual Delivery |
20.2M | 34.7% | - | -73.0% | - | -97.7% |
| KALA Kala |
Pharmaceuticals
Eye Disease Therapies, Corneal |
10.8M | 26.5% | - | -62.9% | - | -74.9% |
| NBY NovaBay |
Pharmaceuticals
Eyecare, Wound Care, Skin Care |
9.19M | 52.1% | 30.2% | -41.6% | 0.67 | 155% |